ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

Tighter Payment Policy

November 5, 2010

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007